• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PYGO2通过减少食管癌细胞的凋亡和G2/M期细胞周期阻滞来促进对化疗的抗性。

PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells.

作者信息

Ardalan Moghadam Al Fatemeh, Forghanifard Mohammad Mahdi, Zarrinpour Vajiheh

机构信息

Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran.

出版信息

Med Oncol. 2025 Jan 14;42(2):45. doi: 10.1007/s12032-024-02590-4.

DOI:10.1007/s12032-024-02590-4
PMID:39808374
Abstract

5-FU is a widely used chemotherapy drug for esophageal carcinomas, but therapy failure has been observed in 5-FU-resistant patients. Overcoming this resistance is a significant challenge in cancer treatment, requiring identifying and targeting important resistance mechanisms. PYGO2 expression is crucial in developing resistance to various chemotherapy drugs. In this study, we aimed to investigate the impact of PYGO2 overexpression on the sensitivity of YM-1 and KYSE-30 esophageal carcinoma cells against 5-FU. To do this, we compared cell viability, cell cycle arrest, apoptosis rate, and mRNA expressions of various apoptosis-related genes between pcDNA3-PYGO2 transfected and untransfected KYSE-30 and YM-1 esophageal carcinoma cells following treatment with 5-FU. We showed that PYGO2 expression reduces 5-FU sensitivity in YM-1 and KYSE-30 cells. PYGO2-overexpressing cells treated with 5-FU have exhibited a noteworthy reduction in both early and late apoptotic cells compared to controls. Furthermore, a significant decrease in the Bax/Bcl2 ratio and P53 gene expression was observed. 5-FU induces G2/M cell cycle arrest in YM-1 and KYSE-30 cells. However, PYGO2 overexpression impeded G2/M cell cycle arrest in 5-FU-treated cells, thereby suppressing the toxicity of 5-FU. PYGO2 may mediate its apoptotic effect by regulating cell cycle regulatory proteins, specifically cyclin D1 and p21. These results highlight PYGO2's capacity to alter how esophageal cancer cells respond to 5-FU therapy, emphasizing its importance as a potential focal point for treatment strategies.

摘要

5-氟尿嘧啶是一种广泛用于治疗食管癌的化疗药物,但在对5-氟尿嘧啶耐药的患者中已观察到治疗失败。克服这种耐药性是癌症治疗中的一项重大挑战,需要识别并靶向重要的耐药机制。PYGO2的表达在对各种化疗药物产生耐药性的过程中至关重要。在本研究中,我们旨在探讨PYGO2过表达对YM-1和KYSE-30食管癌细胞对5-氟尿嘧啶敏感性的影响。为此,我们比较了用5-氟尿嘧啶处理后,转染pcDNA3-PYGO2的和未转染的KYSE-30及YM-1食管癌细胞之间的细胞活力、细胞周期阻滞、凋亡率以及各种凋亡相关基因的mRNA表达。我们发现,PYGO2的表达降低了YM-1和KYSE-30细胞对5-氟尿嘧啶的敏感性。与对照组相比,用5-氟尿嘧啶处理的PYGO2过表达细胞在早期和晚期凋亡细胞方面均有显著减少。此外,观察到Bax/Bcl2比值和P53基因表达显著降低。5-氟尿嘧啶可诱导YM-1和KYSE-30细胞发生G2/M期细胞周期阻滞。然而,PYGO2过表达阻碍了5-氟尿嘧啶处理细胞中的G2/M期细胞周期阻滞,从而抑制了5-氟尿嘧啶的毒性。PYGO2可能通过调节细胞周期调节蛋白,特别是细胞周期蛋白D1和p21来介导其凋亡作用。这些结果突出了PYGO2改变食管癌细胞对5-氟尿嘧啶治疗反应的能力,强调了其作为治疗策略潜在重点的重要性。

相似文献

1
PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells.PYGO2通过减少食管癌细胞的凋亡和G2/M期细胞周期阻滞来促进对化疗的抗性。
Med Oncol. 2025 Jan 14;42(2):45. doi: 10.1007/s12032-024-02590-4.
2
PYGO2 increases proliferation and migration capacities through critical signaling pathways in esophageal squamous cell carcinoma.PYGO2 通过关键信号通路增加食管鳞状细胞癌的增殖和迁移能力。
J Biochem Mol Toxicol. 2024 Jan;38(1):e23625. doi: 10.1002/jbt.23625.
3
Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.SNX-2112 与 5-FU 联合应用对食管癌细胞表现出拮抗作用。
Int J Oncol. 2015 Jan;46(1):299-307. doi: 10.3892/ijo.2014.2714. Epub 2014 Oct 20.
4
Berberine displays antitumor activity in esophageal cancer cells .小檗碱在食管癌细胞中显示出抗肿瘤活性。
World J Gastroenterol. 2017 Apr 14;23(14):2511-2518. doi: 10.3748/wjg.v23.i14.2511.
5
PYGO2 regulates IL10 and plays immunosuppressive role through ESCC progression.PYGO2通过食管鳞状细胞癌进展调节白细胞介素10并发挥免疫抑制作用。
BMC Mol Cell Biol. 2025 Apr 29;26(1):14. doi: 10.1186/s12860-025-00540-0.
6
Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.低剂量全反式维甲酸增强 CD44(+)肿瘤干细胞对顺铂和 5-氟尿嘧啶的细胞毒性。
Biomed Pharmacother. 2015 Aug;74:243-51. doi: 10.1016/j.biopha.2015.08.019. Epub 2015 Aug 28.
7
Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability.胰岛素样生长因子 1 通过增加存活素稳定性介导氟尿嘧啶化疗耐药在食管癌细胞中。
Apoptosis. 2011 Feb;16(2):174-83. doi: 10.1007/s10495-010-0555-z.
8
Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.长链非编码 RNA LINC00261 通过介导 DPYD 的甲基化依赖性抑制来增强人食管癌细胞对 5-氟尿嘧啶的化疗敏感性。
FASEB J. 2019 Feb;33(2):1972-1988. doi: 10.1096/fj.201800759R. Epub 2018 Sep 18.
9
Licochalcone H Synthesized by Modifying Structure of Licochalcone C Extracted from Glycyrrhiza inflata Induces Apoptosis of Esophageal Squamous Cell Carcinoma Cells.甘草查尔酮 C 结构修饰物甘草查尔酮 H 诱导食管鳞癌细胞凋亡。
Cell Biochem Biophys. 2020 Mar;78(1):65-76. doi: 10.1007/s12013-019-00892-3. Epub 2019 Nov 9.
10
Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma.拉帕替尼,一种表皮生长因子受体(EGFR)和人表皮生长因子受体 2(HER2)的双重抑制剂,与氟尿嘧啶(5-fluorouracil)联用对食管癌具有协同作用。
Oncol Rep. 2012 May;27(5):1639-45. doi: 10.3892/or.2012.1659. Epub 2012 Jan 26.

本文引用的文献

1
PYGO2 increases proliferation and migration capacities through critical signaling pathways in esophageal squamous cell carcinoma.PYGO2 通过关键信号通路增加食管鳞状细胞癌的增殖和迁移能力。
J Biochem Mol Toxicol. 2024 Jan;38(1):e23625. doi: 10.1002/jbt.23625.
2
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer.靶向染色质效应因子 Pygo2 可促进细胞毒性 T 细胞反应并克服前列腺癌的免疫治疗耐药性。
Sci Immunol. 2023 Mar 17;8(81):eade4656. doi: 10.1126/sciimmunol.ade4656. Epub 2023 Mar 10.
3
Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2.
EFNA4 的干扰通过下调 PYGO2 抑制肝癌细胞的增殖、侵袭和血管生成。
Cancer Biol Ther. 2022 Dec 31;23(1):1-12. doi: 10.1080/15384047.2022.2149039.
4
Degradation strategy of cyclin D1 in cancer cells and the potential clinical application.癌细胞中细胞周期蛋白D1的降解策略及其潜在临床应用。
Front Oncol. 2022 Aug 18;12:949688. doi: 10.3389/fonc.2022.949688. eCollection 2022.
5
Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1.Pygo2作为一种新型生物标志物在胃癌中通过上调MDR1来监测耐药性。
J Cancer. 2021 Mar 15;12(10):2952-2959. doi: 10.7150/jca.53356. eCollection 2021.
6
Epidemiology of esophageal cancer: update in global trends, etiology and risk factors.食管癌的流行病学:全球趋势、病因和危险因素的最新进展。
Clin J Gastroenterol. 2020 Dec;13(6):1010-1021. doi: 10.1007/s12328-020-01237-x. Epub 2020 Sep 23.
7
Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.结直肠癌中 Wnt/β-连环蛋白通路的转录调控。
Cells. 2020 Sep 19;9(9):2125. doi: 10.3390/cells9092125.
8
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.LncRNA PVT1 通过调节 miR-619-5p/Pygo2 和 miR-619-5p/ATG14 轴,通过激活 Wnt/β-catenin 和自噬途径促进胰腺癌对吉西他滨的耐药性。
Mol Cancer. 2020 Jul 29;19(1):118. doi: 10.1186/s12943-020-01237-y.
9
Curcumin Loaded in Niosomal Nanoparticles Improved the Anti-tumor Effects of Free Curcumin on Glioblastoma Stem-like Cells: an In Vitro Study.姜黄素载入脂质体纳米粒增强游离姜黄素对神经胶质瘤干细胞样细胞的抗肿瘤作用:一项体外研究。
Mol Neurobiol. 2020 Aug;57(8):3391-3411. doi: 10.1007/s12035-020-01922-5. Epub 2020 May 19.
10
Esophageal carcinoma: Towards targeted therapies.食管癌:迈向靶向治疗。
Cell Oncol (Dordr). 2020 Apr;43(2):195-209. doi: 10.1007/s13402-019-00488-2. Epub 2019 Dec 17.